This topic contains a solution. Click here to go to the answer

Author Question: The answer to the question, To what extent is it necessary for the client to continue in treatment ... (Read 22 times)

nramada

  • Hero Member
  • *****
  • Posts: 580
The answer to the question, To what extent is it necessary for the client to continue in treatment beyond the number of sessions initially authorized is determined through:
 
  a. pretreatment authorization.
  b. concurrent utilization reviews.
  c. application of GAF scale ratings.
  d. formative program evaluation.

Question 2

Which of the following must be demonstrated in order for a mental health professionals to be placed on a provider panel?
 
  a. It must be demonstrated that there is a need for additional panel participants in a given geographic region.
  b. The mental health professional must demonstrate that they follow acceptable diagnosis and treatment procedures.
  c. The mental health provider must be willing to accept reduced fees for service rendered.
  d. all of the above
  e. (a) and (b) only



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ktidd

  • Sr. Member
  • ****
  • Posts: 319
Answer to Question 1

b

Answer to Question 2

d




nramada

  • Member
  • Posts: 580
Reply 2 on: Jul 31, 2018
Excellent


Jsherida

  • Member
  • Posts: 314
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

It is widely believed that giving a daily oral dose of aspirin to heart attack patients improves their chances of survival because the aspirin blocks the formation of new blood clots.

Did you know?

About 60% of newborn infants in the United States are jaundiced; that is, they look yellow. Kernicterus is a form of brain damage caused by excessive jaundice. When babies begin to be affected by excessive jaundice and begin to have brain damage, they become excessively lethargic.

Did you know?

Human kidneys will clean about 1 million gallons of blood in an average lifetime.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Congestive heart failure is a serious disorder that carries a reduced life expectancy. Heart failure is usually a chronic illness, and it may worsen with infection or other physical stressors.

For a complete list of videos, visit our video library